Results of shear resistance experiments. by Hui Cheng (195456)

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Subjects:

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Subjects:

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Subjects:

Supplementing NAD+ counters the effects of Oxamate on metabolism and chemotherapy sensitivity. by Siyu Yuan (7425719)

Subjects:

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Subjects:

RT-qPCR Primer. by Dequan Wang (6007007)

Subjects:

CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

Subjects:

miR-1247-3p plasmid. by Dequan Wang (6007007)

Subjects:

RNA-sequencing data screening for miR-1247-3p target genes. by Dequan Wang (6007007)

Subjects:

Dual luciferase primer. by Dequan Wang (6007007)

Subjects:

shCCND1 plasmid. by Dequan Wang (6007007)

Subjects:

CCND1 promoted chemoresistance in CRC. by Dequan Wang (6007007)

Subjects:

Effect of miR-1247-3p on survival in colorectal cancer patients. by Dequan Wang (6007007)

Subjects:

S1 Raw images - by Dequan Wang (6007007)

Subjects:

Introduction to the dataset. by Dequan Wang (6007007)

Subjects:

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Subjects:

Comparison of base shear time-history before and after structural isolation under various working conditions. by Jie Zhao (49409)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

“…This study develops a small-molecule NIR-II phototherapeutic agent (IRF) with a high fluorescence quantum yield (17.4%), excellent PCE (96.8%) for photothermal therapy (PTT), and photodynamic therapy (PDT) activity. To decrease thermal resistance during phototherapy, IRF and evodiamine (EVO) were loaded onto hyaluronic acid (HA)-modified nanoparticles, creating a multifunctional nanoplatform termed EVO/IRF@HA NPs. …”